Waltham, MA, United States of America

Jin Xu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jin Xu

Introduction

Jin Xu, an accomplished inventor based in Waltham, MA, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he focuses on innovative formulations that advance treatment options for patients, particularly those suffering from multiple sclerosis.

Latest Patents

Jin Xu's latest patents revolve around novel pharmaceutical bead formulations that include dimethyl fumarate. One of his key inventions presents a unique pharmaceutical composition comprising an inert core wrapped in a first layer of dimethyl fumarate, topped with an enteric coating. This design aims to enhance the efficacy and delivery of medication for patients with multiple sclerosis. Another patent details a dual pharmaceutical bead composition that combines an enterically coated immediate-release formulation with a controlled-release version, both containing dimethyl fumarate. These inventions reflect Xu's commitment to improving therapeutic outcomes through innovative pharmaceutical solutions.

Career Highlights

Jin Xu is currently affiliated with Biogen MA Inc., a leading biotech company known for its pioneering work in neurological treatments. His role and contributions play a crucial part in the ongoing mission to develop advanced therapies for various neurological conditions.

Collaborations

Throughout his career, Jin Xu has collaborated with notable individuals in his field, including Shyam B Karki and Peter Zawaneh. These partnerships enhance his research and development efforts, driving forward innovative solutions in pharmaceutical science.

Conclusion

Jin Xu's inventive spirit and dedication to addressing complex medical needs are evident in his work. As he continues to pursue advancements in pharmaceutical technology, his contributions are sure to impact the treatment landscape for multiple sclerosis and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…